Yumin Huang Selected Research

Neoplasms (Cancer)

4/2024	Discovery of Highly Potent and Efficient CBP/p300 Degraders with Strong In Vivo Antitumor Activity.
1/2021	Monoamine Oxidase A Inhibits Lung Adenocarcinoma Cell Proliferation by Abrogating Aerobic Glycolysis.
6/2020	A novel TJP1-ROS1 fusion in malignant peripheral nerve sheath tumor responding to crizotinib: A case report.
1/2020	miR-210-5p promotes epithelial-mesenchymal transition by inhibiting PIK3R5 thereby activating oncogenic autophagy in osteosarcoma cells.
1/2020	High PD‑L1 expression drives glycolysis via an Akt/mTOR/HIF‑1α axis in acute myeloid leukemia.
1/2018	Osteopontin promotes cancer cell drug resistance, invasion, and lactate production and is associated with poor outcome of patients with advanced non-small-cell lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yumin Huang Research Topics

Disease

6	Neoplasms (Cancer) 04/2024 - 01/2018
3	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2018
2	Osteosarcoma (Osteogenic Sarcoma) 01/2022 - 12/2019
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2024
1	Inflammation (Inflammations) 02/2023
1	Acute Kidney Injury (Acute Renal Failure) 01/2023
1	Ascites 01/2023
1	Carcinogenesis 01/2022
1	Lung Neoplasms (Lung Cancer) 01/2022
1	Brain Ischemia (Cerebral Ischemia) 04/2021
1	Reperfusion Injury 04/2021
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 04/2021
1	Adenocarcinoma of Lung 01/2021
1	Neurofibrosarcoma (MPNST) 06/2020
1	Sickle Cell Anemia (Hemoglobin S Disease) 01/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018
1	Osteoarthritis 03/2017
1	Hyperglycemia 01/2016

Drug/Important Bio-Agent (IBA)

3	MicroRNAs (MicroRNA)IBA 04/2021 - 12/2019
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 06/2020
1	Cyclic AMP Response Element-Binding Protein (Cyclic AMP-Responsive DNA-Binding Protein)IBA 04/2024
1	CREB-Binding ProteinIBA 04/2024
1	Sodium Dodecyl Sulfate (Sodium Lauryl Sulfate)IBA 02/2023
1	3-nitrotyrosineIBA 02/2023
1	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2023
1	Cystatin CIBA 01/2023
1	Methylene Blue (Methylthioninium Chloride)FDA Link 01/2023
1	CreatinineIBA 01/2023
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Sincalide FDA Link 01/2022
1	Long Noncoding RNAIBA 01/2022
1	Oxygen (Dioxygen)IBA 04/2021
1	Glucose (Dextrose)FDA LinkGeneric 04/2021
1	Monoamine Oxidase (MAO)IBA 01/2021
1	Keratins (Keratin)IBA 06/2020
1	MyogeninIBA 06/2020
1	CrizotinibIBA 06/2020
1	B7-H1 AntigenIBA 01/2020
1	Fetal Hemoglobin (Hemoglobin F)IBA 01/2020
1	Sirolimus (Rapamycin)FDA Link 01/2020
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2018
1	IntegrinsIBA 01/2018
1	OsteopontinIBA 01/2018
1	PlatinumIBA 01/2018
1	LigandsIBA 01/2018
1	Glycoproteins (Glycoprotein)IBA 01/2018
1	ginsenoside Rg1IBA 03/2017
1	Streptozocin (Streptozotocin)FDA Link 01/2016

Therapy/Procedure

1	Renal Dialysis (Hemodialysis) 01/2023
1	Drug Therapy (Chemotherapy) 01/2018